Celanese CorporationCENYSE

Want to monitor CE?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

who is celanese? we’re engineers, scientists, operators and product developers. we’re innovators, advisers, designers and problem solvers.

Lori Ryerkerk

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

Three Reasons To Own Adobe In 2026

Oil News: Crude Oil Futures Volatile as Iran Tensions Clash with Supply Glut

NTSI: Leveraged Balanced International Equity And Treasury ETF, Strong Strategy And Investment Thesis

Ralph Lauren: Strong Execution And Sales Performance In A Shaky Environment

Parnassus Core Select ETF Q4 2025 Commentary

CQQQ: The China Tech Bet

InterDigital, The Brain Behind Mobile, Is Tackling New Subjects (Rating Upgrade)

EWT: Taiwan A Quiet Emerging Market Leader, Fresh All-Time High, Reiterate Buy

ROSEN, A LONGSTANDING FIRM, Encourages Smart Digital Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SDM

Should You Forget IonQ and Buy These 2 Tech Stocks Instead?

Sempra: A Defensive Way To Gain From The AI-Driven Power Demand Surge

EWD: Priced With A Lot Of Optimism For 2026

BLUE OWL DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Blue Owl Capital Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - OWL

Dorman Products: Strong Performance, Interesting Prospects, Reaffirming 'Hold'

BTDR DEADLINE NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Bitdeer Technologies Group Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BTDR

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

Nova Eye Medical Limited (ELXMF) Q2 2026 Sales/Trading Call Transcript

4DMedical Limited (FDMDF) Discusses Imaging Technology Portfolio and Market Positioning in Cardio-Pulmonary Diagnostics Transcript

AppFolio Stock Still Has Attractive Upside If It Can Grow As I Expected

14% Yield And Monthly Payments: Why I Prefer Dynex Over Annaly Capital